About David Abramowitz

David Abramowitz is a shareholder in Buchanan’s Chicago office, specialising in biotech, pharmaceuticals, and complex Hatch-Waxman and Biologics Price Competition and Innovation Act litigation. He supports clients from product development through litigation, representing major drugs and healthcare products. His expertise includes FDA regulatory issues, IP disputes, and patent strategies across life sciences and consumer sectors. Renowned for his pragmatic approach, David blends scientific insight with legal expertise to navigate the fast-changing landscape of innovation, regulation, and litigation in the biotech and pharmaceutical industries. His work drives strategic success in a dynamic, evolving global market.

Contributions to Global Practice Guide

Life Sciences & Pharma IP Litigation Trends and Developments in USA – Illinois

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.